Knowledge hub

Blog

AI Brain Slice Segmentation – Innovative Solutions for Precision Diagnostics

AI at the Forefront of Modern Radiology Analysis: Brain MRI Use Case
webinar HCS
Game-Changing Insights in HCS with Cell Painting
AI-driven method for identification of hits from phenotypic screening with Cell Painting Assay
Hackathon – March 2023
Ardigen and DKFZ Research Groups Collaborate to Evaluate the TCR-based Therapies (TCR-Ts)
Ardigen at SLAS International Conference & Exhibition 2023
Meet Ardigen phenAID platform
News

Ardigen at PMWC 2023

Mariola Fotin-Mleczek, PhD, Has Joined Ardigen’s Scientific Board
Ardigen supports JUMP-CP Consortium – The World’s Largest Public Cell Painting Dataset
Agnieszka Blum, MD, PhD, Promoted to the Ardigen Management Board
Prof. Dr. med. Michael Schmitt, MHBA in Ardigen’s Scientific Board
Łukasz Dutkiewicz, PhD Welcomed in Ardigen as a Business Development Director
Discover Our Gene Regulation Platform
Unconventional γδ T cells as allogeneic cellular products in immunotherapies for cancer.
Boost Your Way to Successful Therapy: AI for Drug Discovery Days